CD38 and Miyoshi myopathy: Also, efforts are underway to increase CD38 expression on MM cells by treatment with agents such as all‐trans retinoic acid (ATRA) to take advantage of the excellent anti‐CD38 therapeutic options available.[11, 12] However, options to monitor those therapies in real‐time have been few.